The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 05, 2021
Filed:
Jan. 08, 2018
Applicant:
National Health Research Institutes, Miaoli County, TW;
Inventors:
Kak-Shan Shia, Taipei, TW;
Chien-Huang Wu, New Taipei, TW;
Ming-Chen Chou, New Taipei, TW;
Jen-Shin Song, Taipei, TW;
Yun Wang, Miaoli, TW;
Chuan Shih, Carmel, IN (US);
Assignee:
National Health Research Institutes, Miaoli County, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/14 (2006.01); C07D 413/14 (2006.01); C07D 473/16 (2006.01); A61P 35/02 (2006.01); A61P 9/10 (2006.01); A61P 13/12 (2006.01); A61P 25/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); A61P 9/10 (2018.01); A61P 13/12 (2018.01); A61P 25/00 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); C07D 473/16 (2013.01);
Abstract
Heterocyclic compounds of Formula (I) shown herein. Also disclosed is a pharmaceutical composition containing one of the heterocyclic compounds. Further disclosed are methods of using one of the heterocyclic compounds for mobilizing hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation, and for treating tissue injury, cancer, inflammatory disease, and autoimmune disease.